Aileron Therapeutics (ALRN) Institutional Ownership $4.12 +0.27 (+7.01%) (As of 10/31/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aileron Therapeutics (NASDAQ:ALRN)CurrentInstitutional OwnershipPercentage90.89%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$10.73MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$55.95K Get ALRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Aileron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALRN Institutional Buying and Selling by Quarter Ad Porter & CompanyThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Aileron Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/29/2024 KG&L Capital Management LLC13,000$46K0.0%N/A0.060% 9/17/2024University of Texas Texas AM Investment Management Co.1,777,827$4.93M1.0%N/A8.225% 8/20/2024Nantahala Capital Management LLC464,367$1.29M0.1%+82.1%2.148% 8/9/2024Renaissance Technologies LLC24,864$69K0.0%-44.8%0.115% 8/9/2024Warberg Asset Management LLC31,354$86K0.0%N/A0.145% 8/2/2024University of Texas Texas AM Investment Management Co.1,777,827$4.93M1.9%N/A8.225% Get the Latest News and Ratings for ALRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/13/2024Texas Capital Bank Wealth Management Services Inc26,171$174K0.0%+65.9%0.155% 2/8/2024Texas Capital Bank Wealth Management Services Inc15,773$48K0.0%N/A0.323% 2/1/2024Sigma Planning Corp16,580$51K0.0%N/A0.339% 2/15/2023Alerce Investment Management L.P.830,466$1.97M2.3%-95.0%18.288% 2/10/2023Blair William & Co. IL67,867$161K0.0%-94.5%1.495% 1/31/2023KCK LTD.22,341$53K0.1%-95.0%0.492% 10/31/2022KCK LTD.446,817$101K0.2%-30.9%0.492% 4/25/2022 Bailard Inc.128,010$66K0.0%N/A0.141% 2/14/2022Blair William & Co. IL1,067,489$601K0.0%+32.9%1.179% 2/11/2022KCK LTD.646,817$362K0.3%N/A0.714% 2/10/2022Acadian Asset Management LLC85,274$47K0.0%N/A0.094% 2/4/2022Envestnet Asset Management Inc.136,760$77K0.0%+152.4%0.151% 2/2/2022PVG Asset Management Corp50,300$28K0.1%+113.5%0.056% 1/27/2022Morgan Jess S & Co. Inc.100,000$56K0.0%+33.3%0.110% 11/16/2021Keebeck Wealth Management LLC76,000$78K0.0%-51.2%0.084% 11/12/2021Renaissance Technologies LLC734,721$749K0.0%-28.7%0.811% 11/9/2021Morgan Jess S & Co. Inc.75,000$76K0.1%N/A0.083% 11/9/2021Barclays PLC25,279$26K0.0%+235.4%0.028% 11/9/2021 JFS Wealth Advisors LLC31,807$32K0.0%N/A0.035% 10/26/2021 Game Plan Financial Advisors LLC127,000$130K0.1%+27.0%0.140% 8/17/2021Boothbay Fund Management LLC393,015$491K0.0%+11.8%0.434% 8/16/2021State Street Corp71,200$89K0.0%N/A0.079% 8/13/2021Renaissance Technologies LLC1,031,128$1.29M0.0%-17.5%1.142% 8/13/2021Geode Capital Management LLC766,813$958K0.0%+34.1%0.849% 8/13/2021Vanguard Group Inc.3,440,633$4.30M0.0%-5.9%3.809% 8/12/2021Blair William & Co. IL688,044$860K0.0%+99.1%0.762% 8/4/2021Envestnet Asset Management Inc.34,654$43K0.0%+45.1%0.038% 5/21/2021Citadel Advisors LLC46,830$67K0.0%N/A0.052% 5/19/2021Virtu Financial LLC146,341$209K0.0%+746.6%0.162% 5/18/2021BVF Inc. IL5,265,555$7.53M0.3%N/A5.829% 5/18/2021Citadel Advisors LLC46,830$67K0.0%N/A0.052% 5/17/2021Ikarian Capital LLC2,800,000$4.00M0.1%N/A3.100% 5/13/2021Renaissance Technologies LLC1,250,500$1.79M0.0%+97.1%1.385% 5/13/2021Blair William & Co. IL345,594$494K0.0%+29.0%0.383% Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now.5/12/2021Northern Trust Corp127,883$183K0.0%+378.0%0.142% 5/12/2021Geode Capital Management LLC571,738$817K0.0%+149.3%0.633% 5/12/2021Satter Management CO. L.P.16,609,449$23.75M10.5%+118.3%18.394% 5/11/2021Acadian Asset Management LLC134,419$192K0.0%+30.8%0.149% 5/5/2021Wade G W & Inc.100,993$144K0.0%N/A0.112% 5/4/2021Envestnet Asset Management Inc.23,886$34K0.0%+105.2%0.026% 4/28/2021 Game Plan Financial Advisors LLC77,500$112K0.1%+13.1%0.086% 2/11/2021Satter Management CO. L.P.7,609,449$7.91M3.1%N/A9.101% 2/10/2021Renaissance Technologies LLC634,381$660K0.0%-47.3%0.759% 2/9/2021Blair William & Co. IL267,994$279K0.0%+10.8%0.321% 2/4/2021GSA Capital Partners LLP86,562$90K0.0%N/A0.198% 1/20/2021Kestra Advisory Services LLC30,000$33K0.0%N/A0.068% 1/19/2021 Game Plan Financial Advisors LLC68,500$71K0.1%N/A0.156% 11/9/2020Acadian Asset Management LLC40,704$53K0.0%N/A0.102% (Data available from 1/1/2016 forward) ALRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALRN shares? During the previous two years, 10 institutional investors and hedge funds held shares of Aileron Therapeutics. The most heavily invested institutionals were University of Texas Texas AM Investment Management Co. ($4.93M), Alerce Investment Management L.P. ($1.97M), Nantahala Capital Management LLC ($1.29M), Texas Capital Bank Wealth Management Services Inc ($174K), Blair William & Co. IL ($161K), Warberg Asset Management LLC ($86K), and Renaissance Technologies LLC ($69K).Learn more on ALRN's institutional investors. What percentage of Aileron Therapeutics stock is owned by institutional investors? 90.89% of Aileron Therapeutics stock is owned by institutional investors. Learn more on ALRN's institutional investor holdings. Which institutional investors have been buying Aileron Therapeutics stock? The following institutional investors have purchased Aileron Therapeutics stock in the last 24 months: University of Texas Texas AM Investment Management Co. ($3.56M), Nantahala Capital Management LLC ($209.37K), Warberg Asset Management LLC ($31.35K), Texas Capital Bank Wealth Management Services Inc ($26.17K), Sigma Planning Corp ($16.58K), and KG&L Capital Management LLC ($13K). How much institutional buying is happening at Aileron Therapeutics? Institutional investors have bought a total of 3,852,126 shares in the last 24 months. This purchase volume represents approximately $10.73M in transactions. Which Aileron Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Aileron Therapeutics stock in the last 24 months: Alerce Investment Management L.P. ($15.78M), Blair William & Co. IL ($1.16M), KCK LTD. ($624.48K), and Renaissance Technologies LLC ($20.20K). How much institutional selling is happening at Aileron Therapeutics? Institutional investors have sold a total of 17,582,584 shares in the last 24 months. This volume of shares sold represents approximately $42.03M in transactions. Related Companies PDS Biotechnology Major Shareholders Unity Biotechnology Major Shareholders Cumberland Pharmaceuticals Major Shareholders biote Major Shareholders Foghorn Therapeutics Major Shareholders Design Therapeutics Major Shareholders Inozyme Pharma Major Shareholders ProQR Therapeutics Major Shareholders Amylyx Pharmaceuticals Major Shareholders AC Immune Major Shareholders This page (NASDAQ:ALRN) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aileron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.